Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer Meeting Abstract
| Authors: | Leyvraz, S.; Hong, D. S.; Shen, L.; van Tilburg, C. M.; Tan, D. S. W.; Kummar, S.; Lin, J. J.; Doz, F.; McDermott, R.; Albert, C. M.; Berlin, J.; Bielack, S.; Lassen, U. N.; Tahara, M.; Norenberg, R.; Shurshalina, A.; Fellous, M.; Nogai, H.; Xu, R.; Laetsch, T. W.; Drilon, A. |
| Abstract Title: | Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 44 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Oct 01-04 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2021-09-01 |
| Start Page: | 13 |
| Language: | English |
| ACCESSION: | WOS:000760622600027 |
| PROVIDER: | wos |
| DOI: | 10.1159/000518417 |
| Notes: | Meeting Abstract: V101 -- Meeting was also presented virtually -- "Joint Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology (Hybrid Congress)" -- Source: Wos |
